Anika Wranke

900 total citations
20 papers, 443 citations indexed

About

Anika Wranke is a scholar working on Hepatology, Epidemiology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Anika Wranke has authored 20 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 17 papers in Epidemiology and 2 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Anika Wranke's work include Hepatitis C virus research (16 papers), Hepatitis B Virus Studies (13 papers) and Liver Disease Diagnosis and Treatment (9 papers). Anika Wranke is often cited by papers focused on Hepatitis C virus research (16 papers), Hepatitis B Virus Studies (13 papers) and Liver Disease Diagnosis and Treatment (9 papers). Anika Wranke collaborates with scholars based in Germany, Türkiye and Austria. Anika Wranke's co-authors include Heiner Wedemeyer, Markus Cornberg, Michael P. Manns, Svenja Hardtke, Katja Deterding, Benjamin Heidrich, Kerstin Port, J. Kirschner, Birgit Bremer and Max Westphal and has published in prestigious journals such as Hepatology, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Anika Wranke

20 papers receiving 433 citations

Peers

Countries citing papers authored by Anika Wranke

Since Specialization

Citations

This map shows the geographic impact of Anika Wranke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anika Wranke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anika Wranke more than expected).

Fields of papers citing papers by Anika Wranke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anika Wranke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anika Wranke. The network helps show where Anika Wranke may publish in the future.

Co-authorship network of co-authors of Anika Wranke

This figure shows the co-authorship network connecting the top 25 collaborators of Anika Wranke. A scholar is included among the top collaborators of Anika Wranke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anika Wranke. Anika Wranke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long‐term outcome of hepatitis delta in different regions world‐wide: Results of the Hepatitis Delta International Network 2024 ·Liver International ·Anika Wranke, (unknown), (unknown), George Ν. Dalekos, Mario Rizzetto, (unknown), Grazia Anna Niro, Onur Keskın, (unknown), (unknown), Patrick Ingiliz, Marion Muche, Marı́a Buti, Mathias Jachs, Thomas Vanwolleghem, Markus Cornberg, Zaigham Abbas, Cihan Yurdaydın, (unknown), Heiner Wedemeyer, (unknown)	4
2	Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection 2023 ·Hepatology International ·Anika Wranke, Benjamin Heidrich, Katja Deterding, (unknown), J. Kirschner, Birgit Bremer, Markus Cornberg, Heiner Wedemeyer	14
3	[The interdisciplinary orthogeriatric ward round : Recommendations for the clinical routine]. 2021 ·PubMed ·(unknown), (unknown), Anika Wranke, (unknown), (unknown), Jessica Rademacher, Dirk O. Stichtenoth, Olaf Krause	3
4	Die interdisziplinäre alterstraumatologische Visite 2020 ·Der Unfallchirurg ·(unknown), (unknown), Anika Wranke, (unknown), (unknown), Jessica Rademacher, Dirk O. Stichtenoth, Olaf Krause	5
5	Ten‐year follow‐up of a randomized controlled clinical trial in chronic hepatitis delta 2020 ·Journal of Viral Hepatitis ·Anika Wranke, Svenja Hardtke, Benjamin Heidrich, George Ν. Dalekos, Kendal Yalçın, Fehmı Tabak, Selım Gürel, Yılmaz Çakaloğlu, Ulus Salih Akarca, Frank Lammert, Dieter Häussinger, Tobias Müller, (unknown), Michael P. Manns, Ramazan Idılman, Markus Cornberg, Heiner Wedemeyer, Cihan Yurdaydın	49
6	Soluble immune markers in the different phases of chronic hepatitis B virus infection 2019 ·Scientific Reports ·Steffen B. Wiegand, (unknown), Anika Wranke, (unknown), Jerzy Jaroszewicz, Cheng‐Jian Xu, Yang Li, Michael P. Manns, Thomas Lengauer, Heiner Wedemeyer, Anke Kraft, Christine S. Falk, Markus Cornberg	23
7	Treatment strategies for patients with decompensated liver cirrhosis due to hepatitis C virus infection eligible for liver transplantation: real-life data from five German transplant centers 2019 ·European Journal of Gastroenterology & Hepatology ·Lisa Sandmann, Petra Dörge, Anika Wranke, Johannes Vermehren, Tania M. Welzel, Christoph P. Berg, (unknown), Karl-Heinz Weiss, (unknown), Martina Sterneck, Moritz von Wulffen, Michael P. Manns, Heiner Wedemeyer, Svenja Hardtke, Thomas von Hahn	6
8	Risk factors and seroprevalence of hepatitis E evaluated in frozen‐serum samples (2002‐2003) of pregnant women compared with female blood donors in a Southern region of Brazil 2018 ·Journal of Medical Virology ·Svenja Hardtke, Rodrigo Rocco, (unknown), (unknown), (unknown), Anika Wranke, (unknown), (unknown), Eliane Mara Cesário Pereira Maluf, Heiner Wedemeyer, (unknown)	14
9	Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy 2018 ·Journal of Viral Hepatitis ·(unknown), Anika Wranke, Julia Hengst, Cihan Yurdaydın, Judith Stift, Birgit Bremer, Svenja Hardtke, Onur Keskın, Ramazan Idılman, Michael P. Manns, H. P. Dienes, Christine S. Falk, Heiner Wedemeyer, Benjamin Heidrich	19
10	Dose‐dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis 2018 ·Liver International ·Tammo Lambert Tergast, Anika Wranke, H. Laser, (unknown), Michael P. Manns, Markus Cornberg, Benjamin Maasoumy	33
11	A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study 2018 ·Journal of Hepatology ·Anika Wranke, Cihan Yurdaydın, Benjamin Heidrich, (unknown), Kendal Yalçın, (unknown), (unknown), Frank Lammert, Dieter Häussinger, Thomas Müller, (unknown), M.P. Manns, Heiner Wedemeyer, Svenja Hardtke	1
12	Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis 2017 ·Alimentary Pharmacology & Therapeutics ·(unknown), Bernhard Schlevogt, Katja Deterding, Anika Wranke, (unknown), Kerstin Port, M P Manns, Arndt Vogel, Markus Cornberg, Heiner Wedemeyer	54
13	A phase 2 dose-escalation study of lonafarnib plus ritonavir in patients with chronic hepatitis D: final results from the Lonafarnib with ritonavir in HDV-4 (LOWR HDV-4) study 2017 ·Journal of Hepatology ·Heiner Wedemeyer, Kerstin Port, Katja Deterding, Anika Wranke, J. Kirschner, Benedetto Bruno, (unknown), Jeffrey S. Glenn, (unknown), M.P. Manns	38
14	Interferon-free therapy of chronic hepatitis C does not change the short-term risk for de novo hepatocellular carcinomas in patients with liver cirrhosis 2017 ·Journal of Hepatology ·(unknown), Bernhard Schlevogt, Katja Deterding, Anika Wranke, Kerstin Port, M.P. Manns, Andrea Vogel, Markus Cornberg, H. Wedemeyer	2
15	The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus–Specific T Cells 2016 ·The Journal of Infectious Diseases ·(unknown), Jan Grabowski, (unknown), Birgit Bremer, Anika Wranke, Sebastian Lunemann, Verena Schlaphoff, J. Kirschner, Svenja Hardtke, Michael P. Manns, Markus Cornberg, Heiner Wedemeyer, Pothakamuri Venkata Suneetha	33
16	Antiviral treatment and liver‐related complications in hepatitis delta 2016 ·Hepatology ·Anika Wranke, Beatriz Calle Serrano, Benjamin Heidrich, J. Kirschner, Birgit Bremer, Patrick Lehmann, Svenja Hardtke, Katja Deterding, Kerstin Port, Max Westphal, Michael P. Manns, Markus Cornberg, Heiner Wedemeyer	77
17	Antiviral therapy of hepatitis delta virus infection — progress and challenges towards cure 2016 ·Current Opinion in Virology ·Anika Wranke, Heiner Wedemeyer	21
18	Non‐invasive fibrosis score for hepatitis delta 2016 ·Liver International ·(unknown), Anika Wranke, Cihan Yurdaydın, (unknown), Max Westphal, Ralf Lichtinghagen, Judith Stift, Birgit Bremer, Svenja Hardtke, Onur Keskın, Ramazan Idılman, Armin Koch, Michael P. Manns, Hans Peter Dienes, Heiner Wedemeyer, Benjamin Heidrich	42
19	P0638 : Global epidemiology of hepatitis delta: First data from the hepatitis delta international network 2015 ·Journal of Hepatology ·Svenja Hardtke, Zaigham Abbas, Saeed Hamid, Emanoil Ceaușu, George Ν. Dalekos, Grazia Anna Niro, Giampaolo Corti, (unknown), Raymundo Paraná, Nikolaos Gatselis, Adriana Moţoc, Patrick Ingiliz, Marion Muche, Anika Wranke, (unknown), Cihan Yurdaydın, M.P. Manns, Heiner Wedemeyer	1
20	Current Management of HBV/HDV Coinfection and Future Perspectives 2015 ·Current Hepatology Reports ·Anika Wranke, Benjamin Heidrich, Svenja Hardtke, Heiner Wedemeyer	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact